12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 01/30 12:05
Gainers
- VivoSim Labs (NASDAQ:VIVS) stock rose 72.9% to $2.94 during Friday's pre-market session. The market value of their outstanding shares is at $4.4 million.
- Adlai Nortye (NASDAQ:ANL) stock rose 59.57% to $10.42. The company's market cap stands at $240.9 million.
- OneMedNet (NASDAQ:ONMD) stock increased by 11.64% to $0.88. The company's market cap stands at $40.2 million.
- Elutia (NASDAQ:ELUT) shares moved upwards by 11.42% to $1.17. The company's market cap stands at $44.8 million.
- Iridex (NASDAQ:IRIX) stock rose 10.06% to $1.64. The company's market cap stands at $25.6 million.
- Century Therapeutics (NASDAQ:IPSC) shares increased by 8.95% to $2.19. The market value of their outstanding shares is at $175.4 million.
Losers
- GridAI Technologies (NASDAQ:GRDX) shares fell 58.6% to $1.18 during Friday's pre-market session. The market value of their outstanding shares is at $9.5 million.
- Nuwellis (NASDAQ:NUWE) stock decreased by 19.58% to $3.37. The company's market cap stands at $3.7 million.
- AIxCrypto Holdings (NASDAQ:AIXC) stock decreased by 15.79% to $1.6. The company's market cap stands at $9.8 million.
- Healthcare Triangle (NASDAQ:HCTI) stock fell 14.64% to $0.26. The market value of their outstanding shares is at $3.2 million.
- Serina Therapeutics (AMEX:SER) stock fell 14.13% to $3.04. The market value of their outstanding shares is at $37.7 million.
- QT Imaging Holdings (NASDAQ:QTI) stock fell 12.22% to $5.03. The company's market cap stands at $68.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.